The long-acting parenteral iron chelator, hydroxyethyl starch- deferoxamine, fails to protect against alcohol-induced liver injury in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 2, 1997, Pages 1038-1042

  Sadrzadeh, S M Hossein ^a   Hallaway, Philip E ^b   Nanji, Amin A ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Biomedical Frontiers Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHELATING AGENT; CORN OIL; DEFEROXAMINE; HETASTARCH; IRON;

ALCOHOL BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG LIVER LEVEL; FATTY LIVER; HEPATITIS; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; IRON CHELATION; LIPID PEROXIDATION; LIVER NECROSIS; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUBE FEEDING;

ALANINE TRANSAMINASE; ANIMALS; DEFEROXAMINE; ETHANOL; HETASTARCH; IRON; IRON CHELATING AGENTS; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 0030999169     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. ARTISS, J. D., VINOGRADOV, S. AND ZAK, B.: Spectrophotometric study of several sensitive reagents for serum iron. Clin. Biochem, 14: 311-315, 1982.
2. BACON, B. R. AND BRITTON, R. S.: The pathology of hepatic iron overload: A free radical-mediated process, Hepatology 11: 127-137, 1990.
3. BONKOVSKY, H. L.: Iron and the liver. Am. J. Med. Sci. 301: 32-43, 1991.
4. BONKOVSKY, H. L., BANNER, B. F., LAMBRECHT, R. W. AND RUBIN, R. B.: Iron in liver diseases other than hemochromatoais. Semin. Liver Dis. 16: 65-82, 1996.
5. BRAUGHLER, J. M., CHASE, R. L. AND PREGENZER, J. F.: Stimulation and inhibition of iron-dependent lipid peroxidation by desferrioxamine. Biochem. Biophys. Res. Commun. 153: 933-938, 1988.
6. BRITTENHAM, G. M.: Development of iron-chelating agents for clinical use. Blood 80: 569-574, 1992.
7. CEDERBAUM, A. I.: Role of lipid peroxidation and oxidative stress in alcohol toxicity. Free Radical Biol. Mod. 7: 537-539, 1989.
8. DAVIES, M. J., DONKOR, R., DUNSTER, C. A., GEE, C. A., JONAS, S. AND WILLSON, R. L.: Desferrioxamine (Deaferal) and Superoxide free radicals: formation of an enzyme-damaging nitroxide. Biochem. J. 246: 725-729, 1987.
9. FRENCH, S. W., MIYAMOTO, K. AND TSUKAMOTO, H.: Ethanol-induced fibrosis in the rat: role of the amount of dietary fat. Alcohol. Clin. Exp. Res. 10: 13S-19S, 1986.
10. HALLAWAY, P. E., EATON, J. W., PANTER, S. S. AND HEDLUND, B. E.: Modulation of deaferrioxamine toxicity and clearance by covalent attachment to biocompatible polymers. Proc. Natl. Acad. Sci. U.S.A. 96: 10108-10112, 1989.
11. HERSHKO, C. AND WEATHERALL, D. J.: Iron-chelating therapy. CRC Crit. Rev. Clin. Lab. Sci. 26: 303-345, 1988.
12. HULCRANTZ, R., BISSELL, D. M. AND ROLL, F. J.: Iron mediates production of a neutrophil chemoattractant by rat hepatocytes metabolizing ethanol. J. Clin. Invest. 87: 45-49, 1991.
13. JACOBS, D. M., JULSRUD, J. M. AND BUBRICK, M. P.: Iron chelation with a desferrioxamine conjugate in hemorrhagic shock. J. Surg. Res. 51: 484-490, 1991.
14. MINOTTI, G.: Sources and role of iron in lipid peroxidation. Chem. Res. Toxicol. 6: 134-146, 1992.
15. MINOTTI, G. AND AUST, S. D.: The role of iron in oxygen radical mediated lipid, peroxidation. Chem. Biol. Interact. 71: 1-19, 1989.
16. MOREHOUSE, K. M., FLITTER, W. D. AND MASON, R. P.: The enzymatic oxidation of Desferal to a nitroxide free radical. FEBS Lett. 222: 246-250, 1987.
17. NANJI, A. A. AND FRENCH, S. W.: Dietary linoleic acid is required for development of experimentally induced alcoholic liver injury. Life Sci. 44: 223-227, 1989.
18. NANJI, A. A., KHWAJA, S., TAHAN, S. R. AND SADRZADEH, S. M. H.: Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease. J. Pharmacol. Exp. Ther. 269: 1280-1285, 1994.
19. NANJI, A. A., MENDENHALL, C. L. AND FRENCH, S. W.: Beef fat prevents alcoholic liver disease in the rat. Alcohol. Clin. Exp. Res. 13: 15-19, 1989.
20. PIETRANGELO, A., GUALDI, R., GASALGRANDI, G., MONTOSI, G. AND VENTURA, E.: Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents J. Clin. Invest. 95: 1824-1831, 1995.
21. RECKNAGEL, R. O. AND GLENDE, E. A.: Spectrophotometric determination of lipid conjugated dienes. Methods Enzymol. 105: 331-337, 1984.
22. REINKE, L. A., LAI, E. K., DUBOSE, C. M. AND MCCAY, P. B.: Reactive free radical generation 171 vivo on heart and liver of ethanol-fed rats: Correlation with radical formation in vitro. Proc. Nat. Acad. Sci. U.S.A. 84: 9223-9227, 1987.
23. ROZA, A. M., SLAKEY, D. P., PIEPER, G. M., YE, T. M. V., MOORE-HILTON, G., KOMOROWSKI, C., JOHNSON, P., HEDLUND, B. AND ADAMS, M. B.: Hydroxyethyl starch desferrioxamine, a novel iron chelator, delays diabetes in BB rats J. Lab. Clin. Med. 123: 556-560, 1994.
24. SADRZADEH, S. M. H., NANJI, A. A. AND PRICE, P. L.: The oral iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one reduces hepatic free iron, lipid peroxidation and fat accumulation in chronically ethanol-fed rats. J. Pharmacol. Exp. Ther. 269: 632-636, 1994.
25. SAKAIDA, I., KAYANO, K., WASAKI, S., NAGATOMI, A., MATSUMURA, Y. AND OKITA, K.: Protection against acetaminophen-induced liver injury in vivo by an iron chelator, deferoxamine. Scand. J. Gastroenterol. 30: 61-67, 1995.
26. TSUKAMOTO, H., GAAL, K. AND FRENCH, S. W.: Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: Status report. Hepatology 12: 599-608, 1990.
27. TSUKAMOTO, H., HORNE, W., KAMIMURA, S., NIEMELA, O., PARKKAILA, S., YLAHERTIUALA, F. AND BRITTENHAM, G. M.: Experimental liver cirrhosis induced by alcohol and iron. J. Clin. Invest. 96: 620-630, 1995.
28. VOOGD, A., SLUTER, W., VAN EJIK, H. G. AND KOSTER, J. F.: Low molecular weight iron and the oxygen paradox in isolated rat hearts. J. Clin. Invest. 90: 2050-2055, 1992.